Annexon ANNX
NASDAQ ANNX
$4.86 +0.02 (+0.52%)
As of: Sep 4, 2026 · 2:40 PM EDT

Annexon (ANNX) Cash from Investing Activities (2019 - 2026)

Annexon (ANNX) posted quarterly Cash from Investing Activities of $27.1 million for Q1 2026, down 72.28% year-over-year from $97.6 million in Q1 2025, and up 202.02% quarter-over-quarter from -$26.5 million in Q4 2025.

Analysis

Annexon (ANNX) Cash from Investing Activities (2019 - 2026) Analysis & Trends

Annexon's Cash from Investing Activities history runs 8 years deep, the most recent figure standing at $27.1 million for Q1 2026.

  • In Q1 2026, Cash from Investing Activities fell 72.28% year-over-year to $27.1 million; the TTM figure through Mar 2026 stood at $119.5 million (up 372.34% YoY), while the FY2025 annual figure was $190.1 million, up 186.86% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at $27.1 million, up from -$26.5 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $97.6 million in Q1 2025, with the low at -$96.6 million in Q2 2024.
  • The 5-year median for Cash from Investing Activities is $14.1 million (2022), against an average of $7.5 million.
  • The sharpest annual moves came in 2022 and 2025: Cash from Investing Activities surged 1203.13% in 2022, then tumbled 2720.65% in 2025.
  • Annexon's Cash from Investing Activities stood at -$43.6 million in 2022, then surged by 94.99% to -$2.2 million in 2023, then soared by 146.36% to $1.0 million in 2024, then sank by 2720.65% to -$26.5 million in 2025, then surged by 202.02% to $27.1 million in 2026.
  • Business Quant data shows ANNX's Cash from Investing Activities at $27.1 million in Q1 2026, -$26.5 million in Q4 2025, and $45.9 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 138.74 Bn 130.89 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.52 Bn 77.52 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn -
4 Moderna 58.04 Bn 52.91 Bn 52.00 Mn 329.00 Mn
5 Revolution Medicines 44.06 Bn 44.06 Bn - -1.66 Bn
6 BeOne Medicines 39.98 Bn 34.88 Bn 1.53 Bn -49.35 Mn
7 Alnylam Pharmaceuticals 35.46 Bn 32.15 Bn 992.69 Mn -363.46 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn - -229.72 Mn
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn 24.51 Mn
10 Annexon 978.58 Mn 978.58 Mn - 39.97 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 39.97 Mn
Mar 31, 2026 27.06 Mn
Dec 31, 2025 -26.52 Mn
Sep 30, 2025 45.87 Mn
Jun 30, 2025 73.08 Mn
Mar 31, 2025 97.62 Mn
Dec 31, 2024 1.01 Mn
Sep 30, 2024 -45.93 Mn
Jun 30, 2024 -96.58 Mn
Mar 31, 2024 -77.30 Mn
Dec 31, 2023 -2.18 Mn
Sep 30, 2023 47.84 Mn
Jun 30, 2023 5.53 Mn
Mar 31, 2023 19.52 Mn
Dec 31, 2022 -43.62 Mn
Sep 30, 2022 14.10 Mn
Jun 30, 2022 19.71 Mn
Mar 31, 2022 68.25 Mn
Dec 31, 2021 33.70 Mn
Sep 30, 2021 -1.28 Mn